查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1765141

全球骨科生物製品市場

Orthobiologics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球骨科生物製劑市場規模將達 90 億美元

全球骨科生物製劑市場規模預計在2024年為71億美元，預計到2030年將達到90億美元，2024年至2030年的複合年成長率為4.2%。報告中分析的細分市場之一—關節內粘稠補充療法，預計其複合年成長率為5.1%，到分析期結束時規模將達到41億美元。合成骨科生物製劑細分市場在分析期間的複合年成長率預計為3.4%。

美國市場規模估計為 19 億美元，中國市場預期複合年成長率為 3.8%

美國骨科生物製劑市場規模預計2024年達到19億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到14億美元，在2024-2030年的分析期間內，複合年成長率為3.8%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為3.9%和3.5%。在歐洲，預計德國市場的複合年成長率為3.1%。

全球骨科生物學市場—主要趨勢與促進因素摘要

什麼是骨科生物學？為什麼它在整形外科醫學中如此重要？

骨科生物製劑是生物衍生質能，用於促進整形外科手術中骨骼、肌肉、肌腱和韌帶的癒合。這些物質包括富血小板血漿 (PRP)、骨移植、幹細胞和透明質酸，旨在透過減少發炎、促進組織再生和加速康復來改善人體的自然癒合過程。骨科生物製劑廣泛用於治療運動傷害、退化性關節疾病和脊椎疾病，為患者提供創傷性較小的手術替代方案，或在某些情況下，作為輔助性治療改善手術效果。透過利用人體的自​​然再生能力，骨科生物製劑是肌肉骨骼治療的一項有希望的進步，可加快癒合速度並減少與傳統治療相關的併發症。越來越多的患者尋求非手術治療方法，以及生物製劑在整形外科生物製藥的廣泛應用。

技術進步如何影響骨科生物學產業？

技術創新正在推動骨科生物製品市場的發展，尤其是在再生醫學和組織工程領域。幹細胞研究的進展拓寬了再生醫學的可能性，基於幹細胞的治療已顯示出修復整形外科患者軟骨、骨骼和軟組織的潛力。改良的富血小板血漿 (PRP) 療法，即將濃縮的血小板注射到受損組織以促進癒合，也提高了各種肌肉骨骼損傷非手術治療的有效性。此外，模擬天然骨特性的合成骨移植材料的開發，為骨科醫生在脊椎融合手術和創傷病例中提供了更多骨再生的選擇。此外，骨科生物製品輸送系統的創新，例如支架和水凝膠的使用，提高了這些治療的精確度和有效性。這些技術進步拓寬了骨科生物製品的應用範圍，使其能夠應用於從關節修復到脊椎畸形等更廣泛的疾病。

骨科生物學最常用於哪些領域？

骨科生物材料主要用於整形外科、運動醫學和創傷護理，在脊椎融合手術、關節修復和軟組織再生方面的應用日益廣泛。在運動醫學中，PRP 和幹細胞療法被廣泛用於治療肌腱炎、韌帶斷裂和軟骨損傷等損傷，幫助運動員更快康復並避免手術。在整形外科中，骨科生物材料經常用於脊椎融合手術等手術，這些手術需要骨移植或人工骨骼替代物來刺激骨骼生長和穩定脊椎。關節重組，特別是膝關節和肩關節的重建，是骨科生物材料經常用於促進組織修復和縮短恢復時間的另一個領域。此外，骨科生物材料也用於治療骨關節炎等退化性關節疾病，幫助緩解疼痛和恢復關節功能。它們也被用於創傷護理，特別是對於需要增強骨癒合的複雜骨折。

什麼因素推動了骨科生物學市場的成長？

骨科生物製品市場的成長受到多種因素的推動，包括肌肉骨骼疾病盛行率的上升、對微創手術的需求不斷成長以及再生醫學的進步。其中一個主要促進因素是全球人口老化，這導致骨關節炎和骨質疏鬆症等整形外科疾病的盛行率居高不下，而骨科生物製品治療可有效治療這兩種疾病。對微創和非手術治療方法的需求不斷成長也是一個關鍵促進因素。幹細胞療法、富血小板血漿 (PRP) 和移植骨替代物等技術進步進一步拓寬了骨科生物製品可治療的疾病範圍，使其更有效且更容易獲得。此外，職業運動員和尋求尖端治療的活躍人士擴大將骨科生物製品應用於運動醫學，這也促進了市場的成長。最後，人們對生物製藥在整形外科醫學中益處的認知不斷提高，以及該領域正在進行的研究和開發，正在推動這些治療方法在臨床和外科環境中的廣泛使用。

部分

產品（關節內粘稠補充療法、合成骨科生物製劑、DBM、BMP、其他產品）；應用（骨關節炎和退化性關節炎、骨折修復、脊椎融合、軟組織損傷、其他應用）

受訪公司範例

  • Arthrex, Inc.
  • Bioventus LLC
  • DePuy Synthes
  • Globus Medical, Inc.
  • K2M Group Holdings, Inc.
  • Kuros Biosciences AG
  • Medtronic PLC
  • NuVasive, Inc.
  • Orthofix International NV
  • RTI Surgical, Inc.
  • SeaSpine Holdings Corporation
  • Stryker Corporation
  • XTANT Medical Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 比賽

簡介目錄
Product Code: MCP13776

Global Orthobiologics Market to Reach US$9.0 Billion by 2030

The global market for Orthobiologics estimated at US$7.1 Billion in the year 2024, is expected to reach US$9.0 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Viscosupplementation, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in the Synthetic Orthobiologics segment is estimated at 3.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 3.8% CAGR

The Orthobiologics market in the U.S. is estimated at US$1.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 3.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Orthobiologics Market - Key Trends & Drivers Summarized

What Are Orthobiologics, and Why Are They Critical in Orthopedic Medicine?

Orthobiologics are biologically derived substances used to enhance the healing of bones, muscles, tendons, and ligaments in orthopedic procedures. These substances, which include platelet-rich plasma (PRP), bone grafts, stem cells, and hyaluronic acid, are designed to improve the body’s natural healing processes by reducing inflammation, promoting tissue regeneration, and accelerating recovery. Orthobiologics are widely used in treatments for sports injuries, degenerative joint diseases, and spinal conditions, offering patients a minimally invasive option to surgery or, in some cases, improving surgical outcomes when used as an adjunct therapy. By leveraging the body’s natural regenerative capacity, orthobiologics represent a promising advancement in musculoskeletal care, providing faster healing and reducing complications associated with traditional treatments. Their growing adoption is being driven by increased patient demand for non-surgical treatment options and the rise of biologics in orthopedic surgery.

How Are Technological Advancements Shaping the Orthobiologics Industry?

Technological innovations are propelling the orthobiologics market forward, particularly in the areas of regenerative medicine and tissue engineering. Advances in stem cell research have expanded the possibilities for regenerative treatments, with stem cell-based therapies showing promise in repairing cartilage, bone, and soft tissues in orthopedic patients. The refinement of platelet-rich plasma (PRP) therapies, where concentrated platelets are injected into damaged tissue to promote healing, has also increased the effectiveness of non-surgical treatments for a variety of musculoskeletal injuries. Furthermore, developments in synthetic bone graft substitutes, which mimic the properties of natural bone, are offering orthopedic surgeons more options for bone regeneration in spinal fusion and trauma cases. Additionally, innovations in the delivery systems for orthobiologics, such as the use of scaffolds or hydrogels, are improving the precision and efficacy of these therapies. These technological advancements are enhancing the scope of orthobiologics, making them more versatile and applicable to a wider range of conditions, from joint repair to spinal deformities.

Where Are Orthobiologics Being Used Most Extensively?

Orthobiologics are primarily used in orthopedic surgeries, sports medicine, and trauma care, with increasing applications in spinal fusion, joint repair, and soft tissue regeneration. In sports medicine, PRP and stem cell therapies are widely used to treat injuries such as tendonitis, ligament tears, and cartilage damage, helping athletes recover faster and avoid surgery. In orthopedic surgery, orthobiologics are frequently used in procedures like spinal fusion, where bone grafts or bone substitutes are needed to promote bone growth and stabilize the spine. Joint reconstruction, particularly in the knee and shoulder, is another area where orthobiologics are commonly employed to enhance tissue repair and reduce recovery times. Moreover, orthobiologics are gaining traction in treating degenerative joint diseases such as osteoarthritis, where they help alleviate pain and restore joint function. Their use in trauma care is also expanding, particularly for complex fractures that require enhanced bone healing.

What Is Driving the Growth of the Orthobiologics Market?

The growth in the orthobiologics market is driven by several factors, including the rising prevalence of musculoskeletal disorders, an increasing demand for minimally invasive procedures, and advancements in regenerative medicine. One of the primary drivers is the aging global population, which is leading to a higher incidence of orthopedic conditions such as osteoarthritis and osteoporosis, both of which benefit from orthobiologic treatments. The growing demand for minimally invasive and non-surgical treatment options is another significant driver, as patients increasingly seek alternatives to traditional surgery for faster recovery and fewer complications. Technological advancements in stem cell therapies, platelet-rich plasma (PRP), and bone graft substitutes are further expanding the range of conditions that can be treated with orthobiologics, making them more effective and accessible. Additionally, the increasing adoption of orthobiologics in sports medicine, driven by professional athletes and active individuals looking for cutting-edge treatments, is contributing to market growth. Lastly, the rising awareness of the benefits of biologics in orthopedic care, coupled with ongoing research and development in the field, is driving the broader use of these therapies in both clinical and surgical settings.

SCOPE OF STUDY:

The report analyzes the Orthobiologics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, Other Products); Application (Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Arthrex, Inc.
  • Bioventus LLC
  • DePuy Synthes
  • Globus Medical, Inc.
  • K2M Group Holdings, Inc.
  • Kuros Biosciences AG
  • Medtronic PLC
  • NuVasive, Inc.
  • Orthofix International NV
  • RTI Surgical, Inc.
  • SeaSpine Holdings Corporation
  • Stryker Corporation
  • XTANT Medical Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Orthobiologics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Musculoskeletal Disorders Spurs Growth in the Orthobiologics Market
    • Growing Demand for Minimally Invasive Surgical Techniques Strengthens Business Case for Orthobiologics
    • Increasing Focus on Regenerative Medicine Drives Adoption of Orthobiologics in Joint Repair and Replacement
    • Advancements in Stem Cell and Growth Factor Therapies Propel Innovation in Orthobiologics
    • Surge in Aging Population and Increasing Incidence of Osteoarthritis Expands Addressable Market for Orthobiologics
    • Growing Focus on Biocompatibility and Bioabsorbable Materials Fuels Innovation in Orthobiologic Products
    • Rising Use of Orthobiologics in Sports Medicine Fuels Growth in Cartilage Repair and Tissue Regeneration
    • Growing Application of Orthobiologics in Fracture Healing Expands Opportunities in Trauma Care
    • Increasing Focus on Personalized Orthopedic Treatments Drives Demand for Orthobiologics in Customized Therapies
    • Expansion of Orthobiologics in Non-Surgical Treatments for Chronic Pain and Joint Degeneration Propels Market Growth
    • Advances in 3D Printing and Biologics-Based Implants Strengthen Market for Orthobiologics in Complex Surgeries
    • Increasing Use of Platelet-Rich Plasma (PRP) in Orthopedic Therapies Expands the Orthobiologics Market
    • Rising Demand for Orthobiologics in Spinal Fusion Procedures Boosts Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Orthobiologics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Orthobiologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Orthobiologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Orthobiologics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Viscosupplementation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Synthetic Orthobiologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Synthetic Orthobiologics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for DBM by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for DBM by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for DBM by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for BMP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for BMP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for BMP by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Osteoarthritis & Degenerative Arthritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Osteoarthritis & Degenerative Arthritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Osteoarthritis & Degenerative Arthritis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Fracture Recovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Fracture Recovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Fracture Recovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Spinal Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Spinal Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Spinal Fusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Soft Tissue Injuries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Soft Tissue Injuries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Soft Tissue Injuries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Orthobiologics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Orthobiologics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Orthobiologics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of World 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of World 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION